Evidence map›Paper›PMID 42793247›Full record

ArticleCurrent issues in molecular biology2026

Integrated Computational Study Prioritizes Drug-like Para-Flavonoids as Candidate SARS-CoV-2 M

Jawaher H Alqahtani, Mohammed Ouachekradi, Bahia Abdelfattah, Amal Elrherabi, Moneerah J Alqahtani, Joe Miantezila Basilua, Oussama Khibech, Mohamed Bouhrim

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jawaher H AlqahtaniDepartment of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-3640-9612
Mohammed OuachekradiLaboratory of Applied Chemistry and Environment, Faculty of Science, Mohammed First University, BP 717, Oujda 60000, Morocco.
Bahia AbdelfattahLaboratory of Physical Chemistry of Materials, Natural Substances and Environment, Chemistry Department, Faculty of Sciences and Techniques of Tangier, Tangier 90090, Morocco.ORCID 0009-0008-8311-2513
Amal ElrherabiLaboratory for Research in Life and Drug Sciences (LRSVM), Pharmacology, Toxicology, and Applied Plant Sciences, Faculty of Medicine and Pharmacy, Mohammed First University, BP 717, Oujda 60000, Morocco.
Moneerah J AlqahtaniDepartment of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.ORCID 0000-0003-3013-1354
Joe Miantezila BasiluaBioSTM-UR 7537 Biostatistics, Processing and Modelling of Biological Data, Paris Cité University, 75006 Paris, France.ORCID 0000-0002-5658-9382
Oussama KhibechLaboratory of Applied Chemistry and Environment, Faculty of Science, Mohammed First University, BP 717, Oujda 60000, Morocco.ORCID 0009-0007-9407-7576
Mohamed BouhrimBiological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, P.O. Box 523, Mghila, Beni Mellal 23000, Morocco.

Funding

King Saud University ORF-2026-583
6 · The paper itself

Abstract

Emerging SARS-CoV-2 variants highlight the need for orally active, low-toxicity antivirals. We designed seven para-substituted flavonoid hybrids (M1-M7) against the main protease (M

Indexed as

ADMEantiviralsdensity-functional calculationsflavonoidGROMACSSARS-CoV-2SDG3

Identifiers

PMID42793247
PMCPMC13605035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.